127 related articles for article (PubMed ID: 37195983)
1. Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiaries.
Song Y; Racette BA; Camacho-Soto A; Searles Nielsen S
PLoS One; 2023; 18(5):e0285011. PubMed ID: 37195983
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs.
Pfeiffer RM; Mayer B; Kuncl RW; Check DP; Cahoon EK; Rivera DR; Freedman DM
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):235-245. PubMed ID: 31684770
[No Abstract] [Full Text] [Related]
3. Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study.
Singh JA; Cleveland J
Rheumatology (Oxford); 2018 Mar; 57(3):451-461. PubMed ID: 29106674
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.
Singh JA; Ramachandaran R; Yu S; Curtis JR
BMC Cardiovasc Disord; 2017 Mar; 17(1):76. PubMed ID: 28288564
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data.
Singh JA; Cleveland J
BMC Med; 2017 Mar; 15(1):59. PubMed ID: 28327188
[TBL] [Abstract][Full Text] [Related]
6. Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.
Loop MS; van Dyke MK; Chen L; Safford MM; Kilgore ML; Brown TM; Durant RW; Levitan EB
J Card Fail; 2019 May; 25(5):343-351. PubMed ID: 30339796
[TBL] [Abstract][Full Text] [Related]
7. Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study.
Chen C; Winterstein AG; Lo-Ciganic WH; Tighe PJ; Wei YJ
PLoS Med; 2022 Mar; 19(3):e1003921. PubMed ID: 35231025
[TBL] [Abstract][Full Text] [Related]
8. Gout and dementia in the elderly: a cohort study of Medicare claims.
Singh JA; Cleveland JD
BMC Geriatr; 2018 Nov; 18(1):281. PubMed ID: 30428833
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol and the risk of stroke in older adults receiving medicare.
Singh JA; Yu S
BMC Neurol; 2016 Sep; 16(1):164. PubMed ID: 27604082
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.
Singh JA; Cleveland JD
Eur Heart J; 2019 Sep; 40(36):3046-3054. PubMed ID: 30919894
[TBL] [Abstract][Full Text] [Related]
11. Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
Jarlenski M; Hyon Baik S; Zhang Y
Am J Prev Med; 2016 Sep; 51(3):301-8. PubMed ID: 27036506
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data.
Singh JA; Cleveland JD
Ann Rheum Dis; 2017 Oct; 76(10):1669-1678. PubMed ID: 28584186
[TBL] [Abstract][Full Text] [Related]
14. Association of Stress-Related Disorders With Subsequent Neurodegenerative Diseases.
Song H; Sieurin J; Wirdefeldt K; Pedersen NL; Almqvist C; Larsson H; Valdimarsdóttir UA; Fang F
JAMA Neurol; 2020 Jun; 77(6):700-709. PubMed ID: 32150226
[TBL] [Abstract][Full Text] [Related]
15. Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study.
Wei YJ; Chen C; Lewis MO; Schmidt SO; Winterstein AG
PLoS Med; 2022 Mar; 19(3):e1003947. PubMed ID: 35290389
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study.
Zhang M; Solomon DH; Desai RJ; Kang EH; Liu J; Neogi T; Kim SC
Circulation; 2018 Sep; 138(11):1116-1126. PubMed ID: 29899013
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.
Singh JA; Yu S
Ann Rheum Dis; 2017 Jan; 76(1):72-78. PubMed ID: 27165177
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol adherence, persistence and patterns of use in individuals with diabetes and gout: A retrospective, population-based cohort analysis.
Weisman A; Tomlinson GA; Lipscombe LL; Perkins BA; Hawker GA
Semin Arthritis Rheum; 2021 Dec; 51(6):1162-1169. PubMed ID: 34555659
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.
Singh JA; Akhras KS; Shiozawa A
Arthritis Res Ther; 2015 May; 17(1):120. PubMed ID: 25963969
[TBL] [Abstract][Full Text] [Related]
20. Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults.
Blank LJ; Acton EK; Thibault D; Willis AW
Age Ageing; 2021 Jan; 50(1):205-212. PubMed ID: 33030514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
